Novartis: all 3,900 studies
Page 39 of 39. Open to participants first (226), then studies with results posted, then the rest; newest registration first within each.
- Safety and Efficacy of AAE581 in Postmenopausal Women With OsteoporosisCompletedNCT00100607Phase 2
- A Study of the Clinical Safety, Tolerability, and Efficacy of Zoledronic Acid Compared to an Oral BisphosphonateCompletedNCT00100555Phase 3
- A Clinical Study to Assess the Effect of Vildagliptin on Postprandial Lipid Parameters in Patients With Type 2 DiabetesCompletedNCT00099957Phase 2
- Efficacy and Safety of Vildagliptin in Combination With Glimepiride in Patients With Type 2 DiabetesCompletedNCT00099944Phase 3
- Efficacy and Safety of Vildagliptin in Combination With Insulin in Patients With Type 2 DiabetesCompletedNCT00099931Phase 3
- Efficacy and Safety of Vildagliptin Compared to Rosiglitazone in Drug Naive Patients With Type 2 DiabetesCompletedNCT00099918Phase 3
- A Clinical Study to Assess the Efficacy and Safety of Three Doses of Vildagliptin in Patients With Type 2 DiabetesCompletedNCT00099905Phase 3
- Efficacy and Safety of Vildagliptin in Combination With Metformin in Patients With Type 2 DiabetesCompletedNCT00099892Phase 3
- Efficacy and Safety of Vildagliptin Compared to Metformin in Drug Naive Patients With Type 2 DiabetesCompletedNCT00099866Phase 3
- Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Patients With Type 2 DiabetesCompletedNCT00099853Phase 3
- Safety and Efficacy of FTY720 in Adult Patients Who Receive a Kidney TransplantCompletedNCT00099801Phase 3
- Safety and Efficacy of FTY720 in Adult Patients Who Receive a Kidney TransplantCompletedNCT00099749Phase 2/3
- Efficacy and Safety of FTY720 in Patients Who Receive a Kidney TransplantCompletedNCT00099736Phase 3
- Non-small Cell Lung Cancer RegistryCompletedNCT00099541Phase 4
- Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's DiseaseCompletedNCT00099242Phase 3
- Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar DisorderCompletedNCT00099229Phase 3
- Efficacy and Safety of Rivastigmine Capsules in Patients With Probable Vascular DementiaCompletedNCT00099216Phase 3
- Efficacy and Safety of FTY720 in Patients Who Receive a Kidney TransplantationCompletedNCT00098735Phase 3
- Safety & Efficacy of Certican in Pediatric de Novo Renal Transplant PatientsCompletedNCT00098241Phase 3
- Dose-Ranging Study in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00098228Phase 2
- Follow-Up Study of Patients Previously Treated With Pimecrolimus Tablets for Chronic Plaque-Type PsoriasisCompletedNCT00098189
- Follow-Up Study of Patients Previously Treated With Pimecrolimus Tablets for Atopic DermatitisCompletedNCT00098150
- Famciclovir Oral Pediatric Formulation in Children 1-12 Years of Age With Varicella Zoster InfectionCompletedNCT00098046Phase 3
- A Study of Safety, Tolerability & Efficacy of Certican in de Novo Heart Transplant (Tx) PatientsCompletedNCT00098007Phase 3
- Safety/Efficacy of Everolimus and Neoral® in Adult Cardiac Transplant Patients With Established Allograft VasculopathyCompletedNCT00097968Phase 3
- Safety and Efficacy of Aliskiren When Added to Standardized Losartan and Optimal Antihypertensive Therapy in Patients With Hypertension, Type 2 Diabetes and ProteinuriaCompletedNCT00097955Phase 2
- Efficacy and Safety of Zoledronic Acid for the Treatment of Osteoporosis in MenCompletedNCT00097825Phase 3
- Switching Osteoporosis Patients Currently on Oral Bisphosphonate to Zoledronic AcidCompletedNCT00097812Phase 3
- Sandostatin LAR® Depot in Patients With Primary Insulin Hypersecretion (PIH) and at Least Moderate ObesityCompletedNCT00094146Phase 2
- Clevidipine in the Postoperative Treatment of Hypertension (ECLIPSE-NIC)CompletedNCT00093925Phase 3
- Clevidipine in the Perioperative Treatment of Hypertension (ECLISPE-SNP)CompletedNCT00093912Phase 3
- Clevidipine in the Perioperative Treatment of Hypertension (ECLIPSE-NTG)CompletedNCT00093886Phase 3
- Everolimus and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Are Not in Complete Cytogenetic Remission After Previous Imatinib MesylateCompletedNCT00093639Phase 1/2
- PKC412, Daunorubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid LeukemiaCompletedNCT00093600Phase 1
- Study of Clevidipine Assessing Its Postoperative Antihypertensive Effect in Cardiac Surgery (ESCAPE-2)CompletedNCT00093262Phase 3
- Study of Clevidipine Assessing Its Preoperative Antihypertensive Effect in Cardiac Surgery (ESCAPE-1)CompletedNCT00093249Phase 3
- Bivalirudin in Patients With Acute Myocardial Infarction (AMI) Undergoing Primary PCICompletedNCT00093184Phase 3
- Comparison of Angiomax Versus Heparin in Acute Coronary Syndromes (ACS)CompletedNCT00093158Phase 3
- A Study to Assess SOM230 in Patients With Pituitary Cushing's DiseaseCompletedNCT00088608Phase 2
- Study Comparing SOM230 Subcutaneously and Sandostatin Subcutaneously in Acromegalic PatientsCompletedNCT00088582Phase 2
- A Prostate Cancer Study in Men Undergoing Androgen Deprivation TherapyCompletedNCT00087659Not applicable
- Non-small Cell Lung Cancer Study US75 (Z-PACT)CompletedNCT00086268Phase 3
- Tifacogin for the Treatment of Patients With Severe Community-Acquired PneumoniaCompletedNCT00084071Phase 3
- Gleevec Trial in Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous LeukemiaCompletedNCT00081926Phase 4
- Comparing Angiomax to Heparin With Protamine in Patients Undergoing Cardiopulmonary Bypass (CPB)CompletedNCT00079586Phase 3
- Angiomax in Patients With HIT/HITTS Type II Undergoing CPBCompletedNCT00079508Phase 3
- Pediatric Hypothalamic ObesityCompletedNCT00076362Phase 4
- Comparing Angiomax to Heparin With Protamine Reversal in Patients OPCABCompletedNCT00073593Phase 3
- Angiomax in Patients With HIT/HITTS Type II Undergoing Off-Pump Coronary Artery Bypass Grafting (CABG) (CHOOSE)CompletedNCT00073580Phase 3
- Study Evaluating TCH346 and Placebo Administered Once Daily in Patients With Amyotrophic Lateral Sclerosis (ALS)CompletedNCT00072709Phase 2
- Safety of ICL670 vs. Deferoxamine in Sickle Cell Disease Patients With Iron Overload Due to Blood TransfusionsCompletedNCT00067080Phase 2
- The Effect of Zoledronic Acid on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation TherapyCompletedNCT00063609Phase 4
- Bisphosphonate Treatment of Osteogenesis ImperfectaCompletedNCT00063479Phase 2
- Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic AnemiasCompletedNCT00061763Phase 2
- Safety & Efficacy of ICL670 vs. Deferoxamine in Beta-thalassemia Patients With Iron Overload Due to Blood TransfusionsCompletedNCT00061750Phase 3
- A Randomized, Double Blind Trial of LdT (Telbivudine) Versus Lamivudine in Adults With Compensated Chronic Hepatitis BCompletedNCT00057265Phase 3
- Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.CompletedNCT00056459Phase 3
- Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal CancerCompletedNCT00056446Phase 3
- Treatment of Von Hippel-Lindau (VHL)-Related Hemangioblastoma With PTK787/ZK 222584CompletedNCT00052013Phase 2
- Pediatric Epilepsy StudyCompletedNCT00050947Phase 3
- Pediatric Epilepsy StudyCompletedNCT00050934Phase 3
- STOP Trial - Sandostatin LAR Depot Trial for the Optimum Prevention of Chemotherapy Induced DiarrheaCompletedNCT00050635Phase 4
- EPO906 in Carcinoid and Other Neuroendocrine TumorsCompletedNCT00050349Phase 2
- HORIZON-PFT: Pivotal Fracture TrialCompletedNCT00049829Phase 3
- Efficacy and Safety of Omalizumab in Patients With Severe Persistent AsthmaCompletedNCT00046748Phase 3
- Evaluating the Ability of Zoledronic Acid to Reduce the Rate of Subsequent Osteoporotic Fractures After a Hip FractureCompletedNCT00046254Phase 3
- Anticoagulant Therapy With Bivalirudin in the Performance of Percutaneous Coronary Intervention in Patients With Heparin-Induced Thrombocytopenia (AT BAT, First Inning)CompletedNCT00043940Phase 3
- Study Of Angiomax In Infants Under Six Months With ThrombosisCompletedNCT00043277Phase 2
- A 12-week, Multicenter, Safety and Dose-ranging Study of 3 Oral Doses of TCH346 in Patients With Amyotrophic Lateral SclerosisCompletedNCT00036413Phase 2
- Open-label Trial on the Effect of I.V. Zoledronic Acid 4 mg on Bone Density in Hormone Sensitive Prostate Cancer Patients With Bone MetastasisCompletedNCT00035997Phase 4
- EPO906 Therapy in Patients With Advanced Kidney CancerCompletedNCT00035243Phase 2
- EPO906 Therapy in Patients With Advanced MelanomaCompletedNCT00035165Phase 2
- EPO906 Therapy in Patients With Advanced Breast CancerCompletedNCT00035126Phase 2
- EPO906 Therapy in Patients With Prostate CancerCompletedNCT00035113Phase 2
- EPO906 Therapy in Patients With Advanced Ovarian, Primary Fallopian, or Primary Peritoneal CancerCompletedNCT00035100Phase 2
- EPO906 Therapy in Patients With Advanced Colorectal CancerCompletedNCT00035087Phase 2
- Treatment With Zoledronic Acid in Patients With Breast Cancer, Multiple Myeloma, and Prostate Cancer With Cancer Related Bone LesionsCompletedNCT00029224Phase 4
- Letrozole in Treating Postmenopausal Women With Metastatic Breast CancerCompletedNCT00014638Phase 4
- STI571 in Treating Patients With Chronic Myelogenous Leukemia in Blast CrisisCompletedNCT00006475Phase 2
- Radiolabeled SMT-487 (Yttrium Y 90-DOTA-tyr3-octreotide) in Treating Patients With Refractory Small Cell Lung Cancer or Metastatic Breast CancerCompletedNCT00006370Phase 2
- Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent CancerCompletedNCT00006368Phase 1
- STI571 Compared With Interferon Alfa Plus Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous LeukemiaCompletedNCT00006343Phase 3
- Octreotide in the Prevention of Diarrhea in Patients Receiving Irinotecan for Metastatic Colon CancerTerminatedNCT00006269Phase 3
- STI571 in Treating Patients With Chronic Myelogenous Leukemia That Has Not Responded to Interferon AlfaCompletedNCT00006053Phase 2
- STI571 in Treating Patients With Accelerated Phase Chronic Myelogenous LeukemiaCompletedNCT00006052Phase 2
- Zoledronate Plus Standard Therapy Compared With Placebo Plus Standard Therapy to Prevent Bone Metastases in Patients With Recurrent Prostate Cancer That Has No SymptomsTerminatedNCT00005073Phase 3
- Zoledronate in Treating Patients With Solid Tumors That Have Spread to the BoneCompletedNCT00003884Phase 3
- Radiolabeled Folic Acid and Imaging to Detect Ovarian CancerCompletedNCT00003763Not applicable
- Safety and Effectiveness of Giving Lamisil to HIV-Positive Subjects With Thrush Who Have Not Responded to Fluconazole TreatmentCompletedNCT00002394Not applicable
- A Randomized, Phase I/II Trial to Assess the Safety and Antiviral Effects of Escalating Doses of A Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Viremia and/or ViruriaCompletedNCT00002268Phase 1
- A Pilot Study to Evaluate the Effects of Subcutaneously Administered Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor in Pediatric HIV-Infected Patients With Neutropenia Secondary to AzidothymidineCompletedNCT00002263Not applicable
- A Phase I, Open Label Trial to Evaluate the Safety, Tolerance and Biological Effects of SDZ ILE-964 (Recombinant Human Interleukin-3, RhIL-3) in HIV Infected Patients With CytopeniaCompletedNCT00002258Phase 1
- A Multicenter Placebo-Controlled Double Blind Study to Evaluate the Efficacy and Safety of Sandostatin ( SMS 201-995 ) in Patients With Acquired Immunodeficiency Related Diarrhea Who Were Either "Responders" or "Non-Responders" in a Prior Placebo-Controlled Double-Blind Sandostatin Study.CompletedNCT00002253Not applicable
- A Multicenter Placebo-Controlled Dose Titration Study to Evaluate the Efficacy and Safety of Sandostatin (SMS 201-995) in the Treatment of Patients With Acquired Immunodeficiency Related DiarrheaCompletedNCT00002252Not applicable
- A Phase I/II Trial to Assess the Safety and Tolerance of Escalating Doses of a Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV RetinitisCompletedNCT00002016Phase 1
- A Phase I/II Study of Recombinant Human GM-CSF in Patients With AIDS Virus Infection and LeukopeniaCompletedNCT00002009Phase 1
- An Open Label Phase I Study of Subcutaneously Administered Recombinant Human GM-CSF in Patients With AIDS Virus Infection and LeukopeniaCompletedNCT00002008Phase 1
- A Pilot Trial Evaluating an Alternating Schedule of Recombinant Human GM-CSF and Azidothymidine in Patients With HIV Infection and LeukopeniaCompletedNCT00002007Not applicable
- A Phase I/II Pilot Study of Simultaneously Administered Rhu GM-CSF ( CHO Cell ) and Azidothymidine ( AZT ) in Patients With Severe HIV Infection and Leukopenia: Pharmacokinetics and FeasibilityCompletedNCT00002006Phase 1
- Investigation Into Delay to Diagnosis of Alzheimer's Disease With Exelon (InDDEx)CompletedNCT00000174Phase 3